申请人:Hoffmann-La Roche Inc.
公开号:US20210355122A1
公开(公告)日:2021-11-18
The present invention relates to compounds of formula (I), wherein R
1
, R
2
, R
3
and R
4
are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.